Chronic cough (cough >8 weeks) — diagnostic approach
chronic-cough · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Cough persisting >8 weeks (subacute 3-8 weeks, acute <3 weeks) in adults. After excluding red flags and reviewing CXR and smoking/drug history, the common triad of upper-airway cough syndrome, asthma/eosinophilic bronchitis, and GORD accounts for most non-smokers with a normal CXR. Empirical sequential treatment trials are standard.
Red flags
- Haemoptysis
- Weight loss, night sweats, fever (TB, malignancy, lymphoma)
- Progressive breathlessness, finger clubbing, abnormal CXR
- Hoarseness, dysphagia, aspiration, or stridor
- Significant smoking history age >40 with new/changed cough
- Recurrent pneumonia or focal signs
Assessment
Differential diagnosis
- Upper-airway cough syndrome (post-nasal drip / rhinosinusitis)
- Asthma / cough-variant asthma / non-asthmatic eosinophilic bronchitis
- Gastro-oesophageal reflux (incl. non-acid/laryngopharyngeal)
- ACE-inhibitor induced cough
- Smoking / COPD / chronic bronchitis
- Post-infectious cough, pertussis
- Serious: lung cancer, TB, bronchiectasis, ILD, heart failure, foreign body
- Chronic cough hypersensitivity syndrome (refractory/unexplained)
Investigations
- History: duration, smoking, ACE inhibitor use, occupational/environmental triggers, reflux and rhinitis symptoms, red-flag features
- CXR in all with chronic cough
- Spirometry +/- bronchodilator reversibility; consider bronchial challenge or FeNO for cough-variant asthma/eosinophilic bronchitis
- Review and STOP any ACE inhibitor (cough can take weeks to settle after withdrawal)
- Targeted tests by suspicion: sputum for AFB/TB (esp. India), induced sputum eosinophils, ENT review/sinus imaging, HRCT if bronchiectasis/ILD suspected
- Consider upper GI assessment/empirical reflux trial; bronchoscopy if localised wheeze/haemoptysis/foreign-body suspicion
Management
- Identify and remove obvious causes: stop smoking, stop ACE inhibitor, treat occupational exposure
- CXR for everyone; act on any abnormality or red flag urgently (2-week-wait cancer pathway if indicated)
- If CXR normal and no red flags, treat the common causes with sequential empirical trials, reviewing response
- Trial 1 - upper-airway cough syndrome: intranasal corticosteroid +/- antihistamine for several weeks
- Trial 2 - asthma/eosinophilic bronchitis: inhaled corticosteroid trial (consider FeNO/sputum eosinophils)
- Trial 3 - reflux: lifestyle measures +/- PPI trial (note limited evidence; address non-acid reflux)
- Each trial run long enough (typically 4-8 weeks) before judging; treat concurrent causes
- Refer to specialist cough/respiratory clinic if refractory or diagnosis unclear; consider neuromodulators for refractory chronic cough
Drugs & doses
Intranasal corticosteroid e.g. fluticasone/mometasone 1-2 sprays each nostril once daily (upper-airway cough syndrome) [verify local product]
Inhaled corticosteroid e.g. beclometasone 200-400 micrograms BD trial for suspected asthma/eosinophilic bronchitis [verify local dose]
Proton pump inhibitor e.g. omeprazole 20-40 mg PO once daily for a trial of several weeks if reflux suspected [verify local dose]
Stop ACE inhibitor; substitute an ARB if antihypertensive needed
Refractory chronic cough (specialist): low-dose morphine, gabapentin, or pregabalin as neuromodulators; speech-therapy cough control [verify eligibility & dose]
Disposition
Outpatient. Urgent respiratory/cancer-pathway referral for red flags or abnormal CXR. Specialist cough clinic for refractory cases.
Complications & pitfalls
- Delayed diagnosis of lung cancer, TB, or ILD
- Cough-related: syncope, rib fracture, incontinence, exhaustion, insomnia, social isolation
- Unnecessary/escalating empirical therapy without benefit
Exam pearls
- Chronic cough with a normal CXR in a non-smoker not on an ACE inhibitor is usually upper-airway cough syndrome, asthma/eosinophilic bronchitis, or reflux — treat these empirically (ACCP / ERS chronic cough guidelines).
- Always stop an ACE inhibitor and allow up to several weeks for the cough to resolve before pursuing other causes.
- In TB-endemic regions, actively exclude pulmonary TB in any chronic cough.
- FeNO or induced-sputum eosinophils help identify steroid-responsive cough (cough-variant asthma / eosinophilic bronchitis).
- Refractory/unexplained chronic cough is increasingly recognised as a cough-hypersensitivity syndrome responsive to neuromodulators and speech therapy (ERS 2020).
- Give each empirical trial enough time and treat concurrent causes together.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.